169 related articles for article (PubMed ID: 20672292)
21. Differences in clinical outcomes of paediatric cystic fibrosis patients with and without meconium ileus.
Tan SMJ; Coffey MJ; Ooi CY
J Cyst Fibros; 2019 Nov; 18(6):857-862. PubMed ID: 31672555
[TBL] [Abstract][Full Text] [Related]
22. Body composition and lung function in children with cystic fibrosis and meconium ileus.
Doulgeraki A; Petrocheilou A; Petrocheilou G; Chrousos G; Doudounakis SE; Kaditis AG
Eur J Pediatr; 2017 Jun; 176(6):737-743. PubMed ID: 28409283
[TBL] [Abstract][Full Text] [Related]
23. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
Lai HJ; Cheng Y; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
[TBL] [Abstract][Full Text] [Related]
24. The impact of meconium ileus on the clinical course of children with cystic fibrosis.
Evans AK; Fitzgerald DA; McKay KO
Eur Respir J; 2001 Nov; 18(5):784-9. PubMed ID: 11757628
[TBL] [Abstract][Full Text] [Related]
25. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
Efrati O; Mei-Zahav M; Rivlin J; Kerem E; Blau H; Barak A; Bujanover Y; Augarten A; Cochavi B; Yahav Y; Modan-Moses D
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of liver disease in cystic fibrosis: a longitudinal study.
Lamireau T; Monnereau S; Martin S; Marcotte JE; Winnock M; Alvarez F
J Hepatol; 2004 Dec; 41(6):920-5. PubMed ID: 15582124
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
[TBL] [Abstract][Full Text] [Related]
28. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function.
Bastardo CM; Sonnappa S; Stanojevic S; Navarro A; Lopez PM; Jaffe A; Bush A
Thorax; 2009 Mar; 64(3):246-51. PubMed ID: 19052050
[TBL] [Abstract][Full Text] [Related]
29. Neonatal screening for cystic fibrosis: long-term clinical balance.
Mastella G; Zanolla L; Castellani C; Altieri S; Furnari M; Giglio L; Lombardo M; Miano A; Sciuto C; Pardo F; Magazzù G
Pancreatology; 2001; 1(5):531-7. PubMed ID: 12120233
[TBL] [Abstract][Full Text] [Related]
30. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
Accurso FJ; Sontag MK; Wagener JS
J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
[TBL] [Abstract][Full Text] [Related]
31. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
32. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
Dankert-Roelse JE; Mérelle ME
J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytic leiomyositis and myenteric ganglionitis are intrinsic features of cystic fibrosis: studies in distal intestinal obstruction syndrome and meconium ileus.
Smith VV; Schäppi MG; Bisset WM; Kiparissi F; Jaffe A; Milla PJ; Lindley KJ
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):42-51. PubMed ID: 19710558
[TBL] [Abstract][Full Text] [Related]
34. Growth and lung function in Asian patients with cystic fibrosis.
Callaghan BD; Hoo AF; Dinwiddie R; Balfour-Lynn IM; Carr SB
Arch Dis Child; 2005 Oct; 90(10):1029-32. PubMed ID: 16177157
[TBL] [Abstract][Full Text] [Related]
35. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
McKay KO; Waters DL; Gaskin KJ
J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
[TBL] [Abstract][Full Text] [Related]
36. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
McPhail GL; Acton JD; Fenchel MC; Amin RS; Seid M
J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
[TBL] [Abstract][Full Text] [Related]
37. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
Keller BM; Aebischer CC; Kraemer R; Schöni MH
J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
[TBL] [Abstract][Full Text] [Related]
38. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Siano M; De Gregorio F; Boggia B; Sepe A; Ferri P; Buonpensiero P; Di Pasqua A; Raia V
Dig Liver Dis; 2010 Jun; 42(6):428-31. PubMed ID: 20034860
[TBL] [Abstract][Full Text] [Related]
39. A cystic fibrosis mutation associated with mild lung disease.
Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal surgery in cystic fibrosis: a 20-year review.
Farrelly PJ; Charlesworth C; Lee S; Southern KW; Baillie CT
J Pediatr Surg; 2014 Feb; 49(2):280-3. PubMed ID: 24528967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
